ChemicalBook--->CAS DataBase List--->149838-21-1

149838-21-1

149838-21-1 Structure

149838-21-1 Structure
IdentificationBack Directory
[Name]

PD-85639
[CAS]

149838-21-1
[Synonyms]

Benzeneacetamide, N-[3-(2,6-dimethyl-1-piperidinyl)propyl]-α-phenyl-
[Molecular Formula]

C24H32N2O
[MDL Number]

MFCD14635427
[MOL File]

149838-21-1.mol
[Molecular Weight]

364.53
Chemical PropertiesBack Directory
[Boiling point ]

548.4±50.0 °C(Predicted)
[density ]

1.026±0.06 g/cm3(Predicted)
[storage temp. ]

room temp
[solubility ]

DMSO: 2mg/mL, clear (warmed)
[form ]

powder
[pka]

15.32±0.46(Predicted)
[color ]

white to beige
[InChI]

1S/C23H31N3O/c1-4-13-23(22(24)27,19-9-6-5-7-10-19)20-11-8-12-21(14-20)26-17(2)15-25-16-18(26)3/h5-12,14,17-18,25H,4,13,15-16H2,1-3H3,(H2,24,27)
[InChIKey]

QNZVKSNHNMBPSR-UHFFFAOYSA-N
[SMILES]

CC1CCCC(C)N1CCCNC(C(C2=CC=CC=C2)C3=CC=CC=C3)=O
Safety DataBack Directory
[Symbol(GHS) ]

Exclamation Mark (GHS07)
GHS07
[Signal word ]

Warning
[Hazard statements ]

H302
[Precautionary statements ]

P301+P312+P330
[WGK Germany ]

WGK 3
[Storage Class]

11 - Combustible Solids
[Hazard Classifications]

Acute Tox. 4 Oral
Hazard InformationBack Directory
[Uses]

PD-85639 is a voltage-gated sodium (Na+) channel blocker that has neuroprotective effects[1][2].
[Biological Activity]

PD-85639 (PD85,639) is a voltage-gated sodium (Na+) channel blocker (75% in 10 min & >95% in 25 min blockage of Na+ current by 25 μM PD85,639; whole-cell patch clamp using primary r at brain neurons) th at is shown to target r at brain Nav1.2 with simultaneous high- and low-affinity modes of binding (EC50 = 56 nM/40% & 20 μM/60% at pH 9.05 nM/28% & 3 μM/72% at pH 7.4against 2 nM [3H]-PD85,639 for binding r at brain synaptosomes; EC50 = 17 nM/39% & 10 μM/61% using at pH 9.0 using r at brain synaptosome membranes) and a fast kinetic (t1/2 = 1.2 at 4°C<0.5 min at 25°C)competitive against the local anesthetic Na+ channel blockers tetracainebupivacaineand mepivacaineas well as Na+ channel activators veratridine and batrachotoxin (K1 = 0.26 μM against 5 nM [3H]-BTX for binding r at neocrotical membranes).
[References]

[1] A V Shindikar, et al. Design, synthesis and in vivo anticonvulsant screening in mice of novel phenylacetamides. Eur J Med Chem. 2006 Jun;41(6):786-92. DOI:10.1016/j.ejmech.2006.03.013
[2] Ioannis Roufos, et al. A Structure-Activity Relationship Study of Novel Phenylacetamides Which Are Sodium Channel Blockers. J. Med. Chem. 1996, 39, 1514-1520.
149838-21-1 suppliers list
Company Name: Hangzhou MolCore BioPharmatech Co.,Ltd.
Tel: +86-057181025280; +8617767106207 , +8617767106207
Website: https://www.molcore.com/
Company Name: TargetMol Chemicals Inc.
Tel: +17819995354 , +17819995354
Website:
Company Name: Energy Chemical  
Tel: 021-58432009 400-005-6266
Website: http://www.energy-chemical.com
Company Name: Beijing Biocreative Technology Co., Ltd.  
Tel: 15522676233
Website: www.bestbaiao.com/
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Website: https://www.targetmol.cn/
Company Name: Merck KGaA  
Tel: 21-20338288
Website: www.sigmaaldrich.cn
Company Name: Biosynth Biological Technology (Suzhou) Co Ltd  
Tel: 51288865780
Website: www.biosynth.com
Tags:149838-21-1 Related Product Information